ETF comparison
IBB vs IHF
Both Healthcare.
iShares Biotechnology ETF · iShares U.S. Healthcare Providers ETF
Holdings overlap
3 positions appear in both funds. Buying equal dollars of IBB and IHF would leave roughly 0.1% of each dollar exposed to the same underlying securities.
Side by side
Sub-score comparison
Tracking quality isn't part of the composite — see what we don't score for why.
Cost difference
IHF is 6 bps cheaper than IBB. On a $100,000 position that's about $60/yr more in fees for IBB.
Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with IBB vs IHF.
Top shared holdings
3 shared in total| # | Holding | In IBB | In IHF | Overlap |
|---|---|---|---|---|
| 1 | Castle Biosciences, Inc. | 0.07% | 0.13% | 0.07% |
| 2 | OPKO Health, Inc. | 0.04% | 0.09% | 0.04% |
| 3 | Fulgent Genetics, Inc. | 0.03% | 0.06% | 0.03% |
Only in IBB
253 total- BlackRock Funds III 9.66%
- Gilead Sciences, Inc. 7.75%
- Amgen, Inc. 7.51%
- Vertex Pharmaceuticals, Inc. 7.44%
- Regeneron Pharmaceuticals, Inc. 7.21%
- Alnylam Pharmaceuticals, Inc. 3.99%
- Insmed, Inc. 3.20%
- Argenx SE 3.07%
- Biogen, Inc. 2.46%
- Natera, Inc. 2.41%
Only in IHF
57 total- UNITEDHEALTH GROUP INCORPORATED 22.48%
- CVS HEALTH CORPORATION 12.81%
- HCA HEALTHCARE, INC. 8.98%
- THE CIGNA GROUP 4.85%
- ELEVANCE HEALTH, INC. 4.79%
- VEEVA SYSTEMS INC. 4.45%
- LABCORP HOLDINGS INC. 4.01%
- QUEST DIAGNOSTICS INCORPORATED 3.91%
- HUMANA INC. 3.79%
- TENET HEALTHCARE CORPORATION 3.01%
Open IBB or IHF at a brokerage
Both funds trade commission-free at major US brokerages.
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.
Holdings overlap is the sum of min(weight_a, weight_b) over positions
matched on ISIN (CUSIP fallback). Methodology: see
/methodology/.
Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.